Repetitive TMS Effective, Safe for Poststroke Neurogenic Overactive Bladder

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Drugs.com

via HealthDay

FRIDAY, May 22, 2026 -- Low-frequency contralesional repetitive transcranial magnetic stimulation (rTMS) is effective and safe for poststroke neurogenic overactive bladder (OAB), according to a study published online April 29 in Neurorehabilitation & Neural Repair.

Mohammed Usman Ali, P.T., Ph.D., from The Hong Kong Polytechnic University, and colleagues examined the efficacy, cost utility, and stroke survivors' experiences of rTMS for neurogenic OAB in a randomized study involving 60 stroke survivors with neurogenic OAB. Participants received active rTMS (30 patients) or sham (30 patients) three times per week for four weeks at the contralesional primary motor cortex (M1). At baseline, week 4, and week 8, the OAB Symptom Score (OABSS), Incontinence Quality of Life (I-QOL), and Brief Resilience Scale (BRS) were measured.

The researchers found that compared with sham, active rTMS significantly improved OABSS, I-QOL, and BRS at weeks 4 and 8 (mean difference, 1.81, 17.48, and 0.25 points, respectively). Lower societal costs were seen in association with active rTMS versus sham (HK$1,267.3 versus 1,839.0), and higher quality-adjusted life-years were observed (0.691 versus 0.571). Excellent tolerability, symptom relief, and acceptability were seen in qualitative data.

"These multidimensional findings support low-frequency contralesional M1 rTMS as a safe, acceptable, and potentially cost-saving treatment for poststroke neurogenic OAB," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-05-23 02:29

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords